Dr. Thavendiranathan discusses the HIMILAYAS trial, looking at exercise interventions for cancer survivors and the STOPMEDCTRCD trial addressing the ongoing efficacy of continuing use of cardiovascular medicines after cancer therapy
Dr. Paaladinesh Thavendiranathan is a cardiologist at the Toronto General Hospital, University Health Network; Associate Professor of medicine at the University of Toronto and a Clinician Investigator.
Learn more about the HIMILAYAS trial here:
https://www.himalayastrial.ca/
Learn more about the STOPMEDCTRCD trial here:
https://classic.clinicaltrials.gov/ct2/show/NCT06183437